Rank;Global Rank;Institution;Country;Sector
1;130;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
2;144;GlaxoSmithKline, United Kingdom;GBR;Companies
3;179;Boehringer Ingelheim GmbH Germany;DEU;Companies
4;291;AstraZeneca, Sweden;SWE;Companies
5;346;AstraZeneca, United Kingdom;GBR;Companies
6;580;Novartis, Switzerland;CHE;Companies